Mid-cap healthcare stocks ranked by quant ratings after earnings season
2026-05-26 10:10:32 ET
- TransMedics: Despite Earnings Miss, Growth Story Remains Intact
- Relay Therapeutics, Inc. (RLAY) Presents at ISSVA World Congress 2026: The Latest in Vascular Anomalies - Slideshow
- Relay Therapeutics: Encouraging Data, Competitive Risks (Downgrade)
- Notable healthcare headlines for the week: UnitedHealth, Boston Scientific, and Eli Lilly in focus
- Zai Lab announces departure of President and COO Josh Smiley
Read the full article on Seeking Alpha
For further details see:
Mid-cap healthcare stocks ranked by quant ratings after earnings seasonNASDAQ: GRDN
GRDN Trading
1.62% G/L:
$41.38 Last:
198,202 Volume:
$41 Open:



